Hudson Acquisition I Corp. Announces Letter of Intent for Business Combination

NEW YORK, March 31, 2023 (GLOBE NEWSWIRE) -- Hudson Acquisition I Corp. (the "Company" or "Hudson") (Nasdaq: HUDA), today announced that it has entered into a letter of intent (the “LOI”) with a target company (the “Target Company”) for a potential business combination (the “Acquisition”). The LOI is not a binding agreement, and it outlines the preliminary terms of the Acquisition and the transactions contemplated herein. The Target Company is a pre-clinical-stage biotechnology company focused on developing intranasal preventives for major disease-causing respiratory viruses.